RecruitingPhase 2NCT06890338
Rare condition
Malignant tumor of fallopian tubes
25
studies recruiting now
as of 7 Sept 2026
197
studies registered in total
as of 7 Sept 2026
6
countries with a recruiting site
as of 7 Sept 2026
24 Mar 2025
most recent study posted
among recruiting studies
Recruiting trials
RecruitingPhase 2NCT06492070
Cryocompression With or Without Cilostazol for the Prevention of Paclitaxel-induced Neuropathy in Patients With Gynecological Cancers
RecruitingPhase 1 / Phase 2NCT05985655
Study to Assess GTAEXS617 in Participants With Advanced Solid Tumors
RecruitingPhase 3NCT06580314
Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer
RecruitingPhase 1 / Phase 2NCT05579366
Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)
Showing the 5 most recently updated recruiting studies, as recorded 7 Sept 2026. Live status on each study page.
See all 25 recruiting studiesWhere recruiting studies are running
Countries with at least one recruiting site among the studies above, 7 Sept 2026. Tap a country to search trials there.
Keep watching
Get an email when a new Malignant tumor of fallopian tubes study opens.
One email a day at most. Unsubscribe with one click.
Used only for these alerts. Privacy.
Support
Patient organisations
We do not yet list a dedicated organisation for this condition. The directories below are the best route.
About Malignant tumor of fallopian tubes
RareTrial does not yet hold a plain-language description of this condition. The most reliable starting point is Orphanet’s expert page, which lists specialist centres, registries and patient organisations.
Treatments being studied
1 approved treatment and 45 in clinical development, from Open Targets (CC BY 4.0). Not medical advice.
Approved: Niraparib Tosylate Monohydrate (Niraparib tosylate component of akeega)
Phase 3Doxorubicin (Adriblastina)
Phase 3Gemcitabine (Gemzar)
Phase 3Topotecan Hydrochloride (Evotopin)
Phase 3Paclitaxel (Abraxane)
Phase 3Alvimopan (Entereg)
Phase 3Thalidomide (Kevadon)
Phase 3Cisplatin (Cisplatin)
Phase 3Binimetinib (Mektovi)
+ 37 more in development
Related conditions
Information, not medical advice. Trial listings are shown as recorded on ClinicalTrials.gov; whether any study is right for you is a decision for you and your clinicians, and eligibility is decided by each research team. Disease information from Orphanet (CC BY 4.0).